Dexcom is about ready to start shipping Medicare orders. As well, they have already submitted the G6 (next generation CGM) for approval. Dexcom is also waiting on a pending FDA approval for integration with Tandem.
You would likely be better off at the Horse Track then betting against Dexcom.
The T Man
How is this company in business? My son recently got a new Animas pump and we have been working for months to get him the Dexcom G4 system which is integrated into his pump. Everything seems good but then Dexcom refers us to Liberty Medical to do the processing, well weeks go by and they don't seem to be doing anything. Now we find out that Dexcom referred us to Edgepark Medical for supplies and we have to start over, apparently Edgepark bought the diabetes part of Liberty Medical abruptly and nothing transferred over. Do some research online and these supplier companies have terrible reputations. This is all because we have too much insurance, Dexcom deals with our primary insurance but not our secondary insurance so they have to find a supplier that deals with both which neither Liberty Medical or Edgepark does. Our primary insurance has a 20% copay which the secondary insurance covers so we'd pay nothing.
I'm not sure I understand why you would put a customer off months from getting set up with your product which will generate years of revenue over about $200? My guess is after all is said and done with Dexcom will net less paying a middleman company than if they just billed the primary insurance and waived our copay.
Checked in with Medtronic and they are willing to set us up with their new pump if we trade in the current pump for $749 and work with us on the CGM and initial supplies to get us using their product. When I called and talked to the Dexcom representative to see if Dexcom would do anything like that she told me she understood if I wanted to switch to Medtronic and to let her know if I still wanted to work on getting Dexcom?
Not sure how a company can operate basically encouraging potential customers to go to your competitor?
The trading setup for DXCM looks very enticing. Im not sure about you guys but awe.SOME-StockS has provided me with some pretty good trade ideas. I messed up executing some of them but thats on me.
Already going back up
According to Yahoo Finance Forward P/E on DXCM is 6853X EPS. Yes....not a typo. And you though AMZN was expensive??? At least P/E is not negative like PODD. But it will be..........
Dex will beat earnings this quarter. As expected.
Total technical breakdown on nearly every metric. Looks bad. No earnings support. Look out below.
So fun when this goes down.... $$$$$ :) :) :)
The breakout has begun (2 weeks ago)....
PKVITALITY WON TECHNOLOGY AWARD 2017 CES SHOW GLUCOSE WATCH
Moved through the 50DMA like a BULL!
as I told everybody in this post look at my prior comments I said Apple will be using Dexcom sensors. Everybody freaking ignored me. now I will make another call and that is profit takers are taking their profits right now. Going to wait till this dips back to 70
At the Apple Worldwide Developers Conference (WWDC) it was just announced their smart watches will be able to pull info from the Dexcom CGMs.
@SMD: How is that Apple "partnership" you were so excited about for their watch that no one wears? Is this the same type of partnership that they have with Google in which THEY PAY Google? You didn't know that did you? Have you ever heard of Roku? It is a TV device that enables to to better navigate your smart TV. My Roku has 4 "branded" buttons so that I can go straight to that service. They are Netflix, Amazon, Rdio, and Hulu. But when I push on the Rdio button nothing happens cause that company already went out of business. But at least they had a great partnership with Roku beforehand that they no doubt paid handsomely for. You are funny SMD. Remember me at $30.00.
Insider trades for Dexcom Inc (DXCM). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long and Short Trading Ideas using Insider Transaction Data.
Yahoo Finance Insights
DXCM is up 4.91% to 71.00
Some info about competition - earnings call transcript:
Regarding the U.S. launch of the MiniMed 670G, we have approximately 750 people taking part in our Customer Training Phase. The feedback has been extremely positive with a continued increase in patient satisfaction levels. We are preparing for a broader launch in June to the more than 20,000 pump users that are enrolled in our Priority Access Program. As stated before, we do not expect revenue growth to ramp substantially until after we have fulfilled the Priority Access orders, given the low revenue associated with the upgrade program.
The latest Tweets from Alex Webb (@atbwebb). Bloomberg @business @technology reporter in SF, via Germany and UK. If you discern an opinion, it's mine. Spam me at awebb25[at]bloomberg[dot]net. San Francisco, CA